TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
RPH Pharmaceuticals AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
20,740
|
17,582
|
13,997 |
Financial expenses |
1,609
|
2,080
|
3,231 |
Earnings before taxes |
3,342
|
4,900
|
-265 |
EBITDA |
6,697
|
5,251
|
3,259 |
Total assets |
27,019
|
37,902
|
22,011 |
Current assets |
8,512
|
21,449
|
7,314 |
Current liabilities |
22,940
|
32,334
|
17,102 |
Equity capital |
3,816
|
5,006
|
4,338 |
- share capital |
9
|
10
![]() |
10 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
14.1%
|
13.2%
|
19.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
16.1%
|
27.9%
|
-1.9% |
Return on assets (ROA) |
18.3%
|
18.4%
|
13.5% |
Current ratio |
37.1%
|
66.3%
|
42.8% |
Return on equity (ROE) |
87.6%
|
97.9%
|
-6.1% |
Change turnover |
4,582
|
3,844
|
-3,752 |
Change turnover % |
28%
![]() |
28%
|
-21% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.